The Efficacy and Safety of Cilostazol in Ischemic Stroke Patients with Peripheral Arterial Disease (SPAD): Protocol of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

MLA

Jiann-Shing, Jeng, et al. “The Efficacy and Safety of Cilostazol in Ischemic Stroke Patients with Peripheral Arterial Disease (SPAD): Protocol of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial.” International Journal of Stroke, vol. 10, Nov. 2014, pp. 123–27. EBSCOhost, https://doi.org/10.1111/ijs.12384.

APA

Jiann-Shing, J., Yu, S., Jiunn-Tay, L., Ruey-Tay, L., Chih-Hung, C., Helen L, P., Huey-Juan, L., Chung-Hsiang, L., Ming-Hui, S., Mu-Chien, S., Chang-Ming, C., Li-Ming, L., Hou-Chang, C., Han-Hwa, H., Hung-Yi, C., Sien-Tsong, C., Henry, M., Chung Y, H., & Ko-Chung, T. (2014). The Efficacy and Safety of Cilostazol in Ischemic Stroke Patients with Peripheral Arterial Disease (SPAD): Protocol of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial. International Journal of Stroke, 10, 123–127. https://doi.org/10.1111/ijs.12384

Chicago

Jiann-Shing, Jeng, Sun Yu, Lee Jiunn-Tay, Lin Ruey-Tay, Chen Chih-Hung, Po Helen L, Lin Huey-Juan, et al. 2014. “The Efficacy and Safety of Cilostazol in Ischemic Stroke Patients with Peripheral Arterial Disease (SPAD): Protocol of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial.” International Journal of Stroke 10 (November): 123–27. doi:10.1111/ijs.12384.